Cargando…
When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702642/ https://www.ncbi.nlm.nih.gov/pubmed/36434429 http://dx.doi.org/10.1007/s40520-022-02304-8 |
_version_ | 1784839701082931200 |
---|---|
author | Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan |
author_facet | Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan |
author_sort | Mujahid, Nadia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9702642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-97026422022-11-28 When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan Aging Clin Exp Res Point of View Springer International Publishing 2022-11-25 2022 /pmc/articles/PMC9702642/ /pubmed/36434429 http://dx.doi.org/10.1007/s40520-022-02304-8 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Point of View Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title_full | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title_fullStr | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title_full_unstemmed | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title_short | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
title_sort | when to opt for preemptive anticoagulation with sars-cov-2 infection in the long-term care facilities |
topic | Point of View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702642/ https://www.ncbi.nlm.nih.gov/pubmed/36434429 http://dx.doi.org/10.1007/s40520-022-02304-8 |
work_keys_str_mv | AT mujahidnadia whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT rajanashna whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT abulyasin whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT vuranagavenkataramakrishna whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT neupaneiva whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT laplantekerry whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities AT gravensteinstefan whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities |